Skip to main content

Immunome

Immunome Inc is a clinical-stage biopharmaceutical enterprise headquartered in Bothell, Washington. The company specializes in the discovery and development of novel targeted therapeutic antibodies designed to treat complex oncological and infectious diseases. Its proprietary research platform leverages human memory B-cell analysis to identify and develop potent antibody candidates. Principal revenue is currently earned through research collaborations, pharmaceutical development partnerships, and capital financing arrangements as clinical assets progress through trials. Immunome Inc is publicly listed on the Nasdaq Stock Market.

6 of the funds FundTelligence covers report a position in Immunome.

Legal name
IMMUNOME
Sector
Health Care
Country
United States
Funds holding it
6
Exposure themes
Cancer, Treatment, Women's Health

Funds holding Immunome

Loading...